Search - tctmd.com

Displaying 61 - 80 of 352

Sort: Relevancy | Date

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Presentation ESC 2019

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Presenter: Deepak Bhatt

September 01, 2019

News Conference News ESC 2019

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Michael O'Riordan

September 01, 2019

Podcast Rox Heart Radio

Apple Heart Study, Wearables, and What Lies Ahead

August 14, 2019

News Daily News

CEC Identifies ‘Prognostically Important’ MIs: CHAMPION PHOENIX

Michael O'Riordan

July 30, 2019

News Industry News

New study finds both components of blood pressure predict heart attack, stroke risk

July 17, 2019

Presentation Fellows 2019

The Evolution in PCI Pharmacology Over the Past 25 Years

Presenter: Deepak L. Bhatt

April 12, 2019

News Daily News

Does PCI Public Reporting Affect Angiography for Out-of-Hospital Cardiac Arrest?

Michael O'Riordan

April 11, 2019

News Conference News EHRA 2019

Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have Been Learned

Todd Neale

March 26, 2019

News Conference News ACC 2019

First Ticagrelor Reversal Agent Shows Quick Onset, Long Duration in Early Results

Yael L. Maxwell

March 25, 2019

News Conference News ACC 2019

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Yael L. Maxwell

March 22, 2019

News Conference News ACC 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

Michael O'Riordan

March 20, 2019

Presentation ACC 2019

First Randomized Human Experience with a Ticagrelor Reversal Agent

Presenter: Deepak L. Bhatt

March 18, 2019

News Daily News

Long-Awaited CABANA Publication Arrives, With Accompanying Quality-of-Life Study

Todd Neale

March 15, 2019

News Conference News CRT 2019

Renal Denervation With Alcohol Infusions Appears Safe, but Clinical Impact Remains Unproven

Yael L. Maxwell

March 06, 2019

News Daily News

Genetic Risk Factor Discovered for Spontaneous Coronary Artery Dissection

Todd Neale

January 18, 2019

News Daily News

Cardiac Complications Are a Common Cause of Readmission Following Endovascular AAA Interventions

Yael L. Maxwell

January 02, 2019

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

News Daily News

Are the Best Hospitals Actually the Best? Analysis Looks at US News & World Report Rankings

Yael L. Maxwell

November 28, 2018

Presentation AHA 2018

REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Presenter: Deepak L Bhatt

November 16, 2018

Advertisement

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Apple Heart Study, Wearables, and What Lies Ahead

CEC Identifies ‘Prognostically Important’ MIs: CHAMPION PHOENIX

New study finds both components of blood pressure predict heart attack, stroke risk

The Evolution in PCI Pharmacology Over the Past 25 Years

Does PCI Public Reporting Affect Angiography for Out-of-Hospital Cardiac Arrest?

Coping With CABANA: Despite Trial Flaws, A-fib Experts Say Lessons Have Been Learned

First Ticagrelor Reversal Agent Shows Quick Onset, Long Duration in Early Results

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

First Randomized Human Experience with a Ticagrelor Reversal Agent

Long-Awaited CABANA Publication Arrives, With Accompanying Quality-of-Life Study

Renal Denervation With Alcohol Infusions Appears Safe, but Clinical Impact Remains Unproven

Genetic Risk Factor Discovered for Spontaneous Coronary Artery Dissection

Cardiac Complications Are a Common Cause of Readmission Following Endovascular AAA Interventions

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Are the Best Hospitals Actually the Best? Analysis Looks at US News & World Report Rankings

REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content